1. Homepage
  2. Equities
  3. Belgium
  4. Euronext Bruxelles
  5. Ion Beam Applications, SA
  6. News
  7. Summary
    IBAB   BE0003766806

ION BEAM APPLICATIONS, SA

(IBAB)
  Report
Real-time Euronext Bruxelles  -  11:35 2022-08-17 am EDT
16.76 EUR   -1.76%
08/02IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy
GL
08/02IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy
AQ
07/13ION BEAM APPLICATIONS : IBA Notice of Half Year 2022 Results and Conference Call
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Ion Beam Applications SA acquired Modus Medical Devices Inc.

05/03/2022 EDT

Ion Beam Applications SA (ENXTBR:IBAB) acquired Modus Medical Devices Inc. on May 3, 2022. Under the transaction, all of the Modus QA team and employees will be joining to the IBA family. Ion Beam Applications SA (ENXTBR:IBAB) completed the acquisition of Modus Medical Devices Inc. on May 3, 2022.


© S&P Capital IQ 2022
All news about ION BEAM APPLICATIONS, SA
08/02IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-t..
GL
08/02IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-t..
AQ
07/13ION BEAM APPLICATIONS : IBA Notice of Half Year 2022 Results and Conference Call
PU
06/30ION BEAM APPLICATIONS : IBA launches the ConformalFLASH® Alliance
PU
06/30Belgium's Ion Beam Wins Contract for Proton Therapy System in Italy
MT
06/30IBA signs contract with Istituto Clinico Humanitas for a Proteus®ONE proton therapy sol..
GL
06/30IBA signs contract with Istituto Clinico Humanitas for a Proteus®ONE proton therapy sol..
AQ
06/30Ion Beam Applications Sa Signs Contract with Istituto Clinico Humanitas for A Proteus®O..
CI
06/29ION BEAM APPLICATIONS, SA : Ex-dividend day for final dividend
FA
06/27ProtOnART - a new consortium for proton online adaptive radiation therapy
AQ
More news
Financials
Sales 2022 350 M 356 M 356 M
Net income 2022 12,3 M 12,5 M 12,5 M
Net cash 2022 118 M 120 M 120 M
P/E ratio 2022 39,9x
Yield 2022 1,19%
Capitalization 493 M 502 M 502 M
EV / Sales 2022 1,07x
EV / Sales 2023 0,93x
Nbr of Employees 1 473
Free-Float 67,3%
Chart ION BEAM APPLICATIONS, SA
Duration : Period :
Ion Beam Applications, SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ION BEAM APPLICATIONS, SA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 16,76 €
Average target price 19,25 €
Spread / Average Target 14,9%
EPS Revisions
Managers and Directors
Olivier Legrain Chief Executive Officer, Director & MD
Soumya Chandramouli Chief Financial Officer
Pierre Mottet Chairman
Yves Jongen Director, Chief Research Officer & MD
Marcel Miller Independent Director
Sector and Competitors